Daniel is head of the newly created Pediatric Center of Excellence at NGT BioPharma Consultants. He is a pharmaceutical executive with over 30 years of experience in pharmaceutical development and he has 10+ years expertise in developing pediatric products. Daniel retired from Janssen R&D LLC (Johnson & Johnson) in 2019 as Sr. Scientific Director, CMC Leader, where he co-chaired the J&J internal pediatric formulation network.

Daniel is a member of the US based International Consortium for Innovation and Quality in Pharmaceutical Development (IQ Consortium), Pediatric Working Group, and has been appointed Formulation Expert for the pan-European “C4C, Conect4Children” initiative. He is also a founding member of the society of “Paediatric Medicines and Health Initiative”, based in Mumbai, India. Daniel is a speaker and moderator at domestic and international conferences with a focus and passion for “developing better medicines for children”.

Daniel is also a Scientific Advisor for the Swiss Tropical & Public Health Institute, University of Basel, Switzerland and in 2020, he joined Johns Hopkins University, School of Medicine, All Children’s Hospital in St. Petersburg, FL as adjunct assistant Professor. Earlier in his career Daniel worked for Sandoz Pharma, Switzerland and Johnson & Johnson/Janssen in New Jersey, US. Daniel holds a degree in Pharmacy (ETH Zurich) and a doctorate from the University of Lausanne, Switzerland.